- Home
- PRT vs BEAT Comparison
PRT vs BEAT Comparison
Compare PRT & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRT | BEAT |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Retail: Computer Software & Peripheral Equipment |
| Sector | Energy | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.5M | 23.9M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | PRT | BEAT |
|---|---|---|
| Price | $1.41 | $0.40 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 37.4K | ★ 1.4M |
| Earning Date | 11-16-2026 | 11-12-2026 |
| Dividend Yield | ★ 15.38% | N/A |
| EPS Growth | N/A | ★ 15.07 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $654.36 | N/A |
| Revenue Next Year | N/A | $1,197.12 |
| P/E Ratio | $7.78 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.33 | $0.36 |
| 52 Week High | $4.00 | $4.00 |
Technical Indicators
Market Signals| Indicator | PRT | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 18.41 | 44.74 |
| Support Level | N/A | $0.38 |
| Resistance Level | $2.32 | $0.52 |
| Average True Range (ATR) | 0.08 | 0.05 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 17.80 | 8.17 |
Price Performance
Historical ComparisonAbout PRT PermRock Royalty Trust Trust Units
PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.